Barclays »

Urogen Pharma shares owned by Barclays

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $560k 37k 14.99
2023-09-30 $48k 3.4k 14.03
2023-06-30 $41k 3.9k 10.51
2023-03-31 $75k 8.1k 9.25
2022-12-31 $131k 15k 8.99
2022-09-30 $31k 3.8k 8.20
2022-06-30 $31k 3.8k 8.20
2022-03-31 $61k 7.0k 8.78
2021-12-31 $261k 28k 9.51
2021-09-30 $198k 12k 16.85
2021-06-30 $102k 6.7k 15.25
2021-03-31 $392k 20k 19.51
2020-12-31 $191k 11k 18.05
2020-09-30 $252k 13k 19.30
2020-06-30 $412k 16k 26.17
2020-03-31 $185k 10k 17.82
2019-12-31 $660k 20k 33.39
2019-09-30 $237k 10k 23.84
2019-06-30 $436k 12k 35.94
2019-03-31 $1.1M 31k 36.92
2018-12-31 $914k 21k 42.94
2018-09-30 $945k 20k 47.25
2018-06-30 $1.1M 23k 49.62
2018-03-31 $1.2M 25k 49.68